Cubist Systematic Strategies’s Avita Medical RCEL Stock Holding History

Cubist Systematic Strategies’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30,426	Closed	-$248K	–	3427
2025 Q1	$248K	Buy	+30,426	New	+$284K	﹤0.01%	2446
2024 Q1	–	Sell	-10,067	Closed	-$138K	–	4176
2023 Q4	$138K	Buy	+10,067	New	+$115K	﹤0.01%	3105
2023 Q3	–	Sell	-13,528	Closed	-$230K	–	3819
2023 Q2	$230K	Buy	13,528 +1,080	+9%	+$15.8K	﹤0.01%	2748
2023 Q1	$174K	Buy	+12,448	New	+$132K	﹤0.01%	3284
2022 Q3	–	Sell	-29,711	Closed	-$141K	–	4671
2022 Q2	$141K	Buy	+29,711	New	+$184K	﹤0.01%	3845
2020 Q2	–	Sell	-7,757	Closed	-$240K	–	2507
2020 Q1	$240K	Buy	7,757 +5,281	+213%	+$219K	0.01%	1632
2019 Q4	$113K	Buy	+2,476	New	+$103K	﹤0.01%	2170

Other funds holding RCEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Cubist Systematic Strategies's RCEL Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of Avita Medical (RCEL) in Q2 2025, closing a stake of 30,426 shares — an estimated $248K sold.

Cubist Systematic Strategies first reported a position in RCEL in Q4 2019 and held it in 7 quarters. The position peaked at $248K in Q1 2025. 80 funds tracked by Wall St. Rank hold RCEL as of Q2 2025.

Cubist Systematic Strategies reported no remaining Avita Medical position as of Q2 2025 after selling out during the quarter.
Cubist Systematic Strategies sold 30,426 Avita Medical shares in Q2 2025, an estimated $248K.
Cubist Systematic Strategies first reported a position in Avita Medical in Q4 2019 and held it in 7 quarters.
Cubist Systematic Strategies's Avita Medical position peaked at $248K in Q1 2025.
80 funds tracked by Wall St. Rank held Avita Medical as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.